Fuan Pharmaceutical (Group)co.,Ltd — Investor Relations & Filings
Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于子公司收到药品注册证书的公告 | 2026-01-26 | Chinese | |
| 2026年第一次临时股东会决议公告 | 2026-01-06 | Chinese | |
| 2026年第一次临时股东会之法律意见书 | 2026-01-06 | Chinese | |
| 关于子公司收到药品注册证书的公告 | 2025-12-22 | Chinese | |
| 关于变更公司2025年度审计机构的公告 | 2025-12-19 | Chinese | |
| 第六届董事会第五次会议决议公告 | 2025-12-19 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 36139642 | 关于子公司收到药品注册证书的公告 | 2026-01-26 | Chinese | ||
| 36139629 | 2026年第一次临时股东会决议公告 | 2026-01-06 | Chinese | ||
| 36139617 | 2026年第一次临时股东会之法律意见书 | 2026-01-06 | Chinese | ||
|
2025
12 filings
| |||||
| 36139612 | 关于子公司收到药品注册证书的公告 | 2025-12-22 | Chinese | ||
| 36139605 | 关于变更公司2025年度审计机构的公告 | 2025-12-19 | Chinese | ||
| 36139593 | 第六届董事会第五次会议决议公告 | 2025-12-19 | Chinese | ||
| 36139592 | 关于召开2026年第一次临时股东会的通知 | 2025-12-19 | Chinese | ||
| 36139582 | 关于子公司收到药品注册证书的公告 | 2025-12-10 | Chinese | ||
| 36139573 | 关于公司产品纳入《国家医保药品目录》的公告 | 2025-12-08 | Chinese | ||
| 36139570 | 关于子公司收到药品注册证书的公告 | 2025-12-01 | Chinese | ||
| 36139569 | 关于子公司收到菲律宾GMP符合性证书的公告 | 2025-11-05 | Chinese | ||
| 36139562 | 关于子公司参与全国药品集中采购拟中选的公告 | 2025-10-28 | Chinese | ||
| 36139553 | 关于为子公司申请银行授信融资提供担保的公告 | 2025-10-27 | Chinese | ||
| 36139541 | 2025年三季度报告 | 2025-10-27 | Chinese | ||
| 36139538 | 第六届董事会第四次会议决议公告 | 2025-10-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Fuan Pharmaceutical (Group)co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55203/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55203 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55203 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55203 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55203}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fuan Pharmaceutical (Group)co.,Ltd (id: 55203)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.